NLM DIR Seminar Schedule
UPCOMING SEMINARS
-
July 15, 2025 Noam Rotenberg
Cell phenotypes in the biomedical literature: a systematic analysis and the NLM CellLink text mining corpus
RECENT SEMINARS
-
July 3, 2025 Matthew Diller
Using Ontologies to Make Knowledge Computable -
July 1, 2025 Yoshitaka Inoue
Graph-Aware Interpretable Drug Response Prediction and LLM-Driven Multi-Agent Drug-Target Interaction Prediction -
June 10, 2025 Aleksandra Foerster
Interactions at pre-bonding distances and bond formation for open p-shell atoms: a step toward biomolecular interaction modeling using electrostatics -
June 3, 2025 MG Hirsch
Interactions among subclones and immunity controls melanoma progression -
May 29, 2025 Harutyun Sahakyan
In silico evolution of globular protein folds from random sequences
Scheduled Seminars on March 1, 2023
Contact NLMDIRSeminarScheduling@mail.nih.gov with questions about this seminar.
Abstract:
Understanding biological networks and how alterations in those networks drive human disease is key to novel treatment strategies. I will give an overview of several methods and resources focused on understanding complex diseases through the lens of network biology. A major topic will be the development and application of the Pathway Commons (PC) molecular interaction resource. PC is based on community-generated formats and ontologies for the representation of biological data (i.e., the Biological Pathway Exchange format and the Systems Biology Graphical Notation). More recent PC development has broadened into areas of crowdsourcing and natural language processing in order to scale with the increase of scientific publishing. I will also cover the use of PC in the creation of drug resistance prediction algorithms and the interpretation of experimental results in the context of biological networks. Additionally, I will discuss work done in collaboration with the National Cancer Institute (NCI) and National Center for Advancing Translational Sciences (NCATS) to structure large data collections. This work helps bridge experimental model systems and patient data for the development of predictive drug response models and the identification of biomarkers and biological process signatures relevant to treatment decisions.